Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2010 (2010), Article ID 848645, 11 pages
http://dx.doi.org/10.1155/2010/848645
Research Article

Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma

1Department of Dermatology, University of Regensburg, 93042 Regensburg, Germany
2Department of Hematology and Oncology, University of Regensburg, 93042 Regensburg, Germany
3Institute of Pathology, University of Regensburg, 93042 Regensburg, Germany
4Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany
5Institute of Clinical Pathology, University of Erlangen, 91054 Erlangen, Germany
6OncoRay - Center for Radiation Research in Oncology, TU Dresden, 01307 Dresden, Germany
7Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091 Zurich, Switzerland

Received 10 March 2009; Accepted 14 April 2009

Academic Editor: Dipak Panigrahy

Copyright © 2010 Stefanie Meyer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Stefanie Meyer, Thomas Vogt, Michael Landthaler, et al., “Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma,” PPAR Research, vol. 2010, Article ID 848645, 11 pages, 2010. doi:10.1155/2010/848645